Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study.

Associations Between Chronic Kidney Disease and Outcomes With Use of Prasugrel Versus Clopidogrel in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Report From the PROMETHEUS Study. JACC Cardiovasc Interv. 2017 10 23; 10(20):2017-2025.

View in: PubMed

subject areas

Acute Coronary Syndrome
Acute Coronary Syndrome
Aged
Aged
Aged, 80 and over
Aged, 80 and over
Chi-Square Distribution
Chi-Square Distribution
Coronary Thrombosis
Coronary Thrombosis
Databases, Factual
Databases, Factual
Hemorrhage
Hemorrhage
Humans
Humans
Kaplan-Meier Estimate
Kaplan-Meier Estimate
Kidney
Kidney
Male
Male
Middle Aged
Middle Aged
Multivariate Analysis
Multivariate Analysis
Myocardial Infarction
Myocardial Infarction
Percutaneous Coronary Intervention
Percutaneous Coronary Intervention
Platelet Aggregation Inhibitors
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Prasugrel Hydrochloride
Propensity Score
Propensity Score
Proportional Hazards Models
Proportional Hazards Models
Renal Insufficiency, Chronic
Renal Insufficiency, Chronic
Risk Factors
Risk Factors
Stroke
Stroke
Ticlopidine
Ticlopidine
Time Factors
Time Factors
Treatment Outcome
Treatment Outcome
United States
United States

authors with profiles

Usman Baber